These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7614929)

  • 1. High-dose tamoxifen in treatment of brain tumors: interaction with antiepileptic drugs.
    Rabinowicz AL; Hinton DR; Dyck P; Couldwell WT
    Epilepsia; 1995 May; 36(5):513-5. PubMed ID: 7614929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of tamoxifen as an antiproliferative agent in vitro for benign and malignant pediatric glial tumors.
    Pollack IF; Kawecki S
    Pediatr Neurosurg; 1995; 22(6):281-8. PubMed ID: 7577661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen.
    Couldwell WT; Weiss MH; DeGiorgio CM; Weiner LP; Hinton DR; Ehresmann GR; Conti PS; Apuzzo ML
    Neurosurgery; 1993 Mar; 32(3):485-9; discussion 489-90. PubMed ID: 8384328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.
    Baltuch GH; Couldwell WT; Villemure JG; Yong VW
    Neurosurgery; 1993 Sep; 33(3):495-501; discussion 501. PubMed ID: 8413883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.
    Couldwell WT; Weiss MH; Law RE; Hinton DR
    J Neurosurg; 1995 Mar; 82(3):461-8. PubMed ID: 7861225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen.
    Couldwell WT; Hinton DR; Surnock AA; DeGiorgio CM; Weiner LP; Apuzzo ML; Masri L; Law RE; Weiss MH
    Clin Cancer Res; 1996 Apr; 2(4):619-22. PubMed ID: 9816211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood.
    Pollack IF; DaRosso RC; Robertson PL; Jakacki RL; Mirro JR; Blatt J; Nicholson S; Packer RJ; Allen JC; Cisneros A; Jordan VC
    Clin Cancer Res; 1997 Jul; 3(7):1109-15. PubMed ID: 9815790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant glioma sensitivity to radiotherapy, high-dose tamoxifen, and hypericin: corroborating clinical response in vitro: case report.
    Zhang W; Hinton DR; Surnock AA; Couldwell WT
    Neurosurgery; 1996 Mar; 38(3):587-90; discussion 590-1. PubMed ID: 8837815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
    Preul MC; Caramanos Z; Villemure JG; Shenouda G; LeBlanc R; Langleben A; Arnold DL
    Neurosurgery; 2000 Feb; 46(2):306-18. PubMed ID: 10690719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of antiepileptic drugs in pediatric brain tumor patients.
    Sogawa Y; Kan L; Levy AS; Maytal J; Shinnar S
    Pediatr Neurol; 2009 Sep; 41(3):192-4. PubMed ID: 19664535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose tamoxifen in the treatment of recurrent high grade glioma: a report of clinical stabilization and tumour regression.
    Baltuch G; Shenouda G; Langleben A; Villemure JG
    Can J Neurol Sci; 1993 May; 20(2):168-70. PubMed ID: 8334583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.
    Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
    Cancer Res; 1990 Nov; 50(22):7134-8. PubMed ID: 2224848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.
    Hercbergs AA; Goyal LK; Suh JH; Lee S; Reddy CA; Cohen BH; Stevens GH; Reddy SK; Peereboom DM; Elson PJ; Gupta MK; Barnett GH
    Anticancer Res; 2003; 23(1B):617-26. PubMed ID: 12680157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways.
    Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
    J Neurosurg; 1990 Jul; 73(1):98-105. PubMed ID: 2161913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.
    Odia Y; Kreisl TN; Aregawi D; Innis EK; Fine HA
    J Neurooncol; 2015 Oct; 125(1):191-5. PubMed ID: 26285768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
    Tang P; Roldan G; Brasher PM; Fulton D; Roa W; Murtha A; Cairncross JG; Forsyth PA
    J Neurooncol; 2006 Jul; 78(3):311-6. PubMed ID: 16710748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparity in expression of protein kinase C alpha in human glioma versus glioma-derived primary cell lines: therapeutic implications.
    Zellner A; Fetell MR; Bruce JN; De Vivo DC; O'Driscoll KR
    Clin Cancer Res; 1998 Jul; 4(7):1797-802. PubMed ID: 9676858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines.
    Couldwell WT; Hinton DR; He S; Chen TC; Sebat I; Weiss MH; Law RE
    FEBS Lett; 1994 May; 345(1):43-6. PubMed ID: 8194597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells.
    Tseng SH; Wang CH; Lin SM; Chen CK; Huang HY; Chen Y
    J Cancer Res Clin Oncol; 2004 May; 130(5):285-93. PubMed ID: 14997384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen as a potential treatment of glioma.
    Mastronardi L; Puzzilli F; Ruggeri A
    Anticancer Drugs; 1998 Aug; 9(7):581-6. PubMed ID: 9773800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.